"Glioblastoma invasion front is approximately eight times more viscous (7.1 cP) than the necrotic core."
A New Window into Brain Cancer Invasion
Researchers at Chongqing General Hospital and Chongqing University have developed an innovative open microfluidic chip that is shedding new light on how fluid viscosity drives the aggressive invasion of glioblastoma cells.
The platform, detailed in Microsystems & Nanoengineering (DOI: 10.1038/s41378-026-01241-0), tackles a critical blind spot in cancer research: the physical environment of the tumor.
The Viscosity Divide
The study reveals a stark physical gradient within glioblastoma tumors: the invasion front is significantly more viscous than the necrotic core. Standard closed microfluidic systems fail to replicate this, suffering from restricted oxygen and nutrient flow, wall friction, and limited observation periods.
The new open design overcomes these hurdles, precisely controlling the start of cell migration and enabling real-time imaging of nuclear deformation. Crucially, it supports long-term culture for up to one month.
Key Findings
- Two human glioblastoma cell lines (U-251 and LN-229) were cultured for one month in a viscous medium matching the invasion front.
- Viscosity-adapted cells migrated farther and faster than control cells. They became smaller and more deformable, allowing them to squeeze through micropillar gaps.
- The YAP protein accumulated in the nucleus under confined conditions, a hallmark of mechanical activation.
Divergent Cellular Responses
The study uncovered distinct adaptation strategies:
- U-251 cells underwent a mesenchymal-like reprogramming, with increased expression of invasion-related genes (CD44, FN1, MMP9).
- LN-229 cells changed shape and migration but showed minimal lasting gene expression changes.
Strikingly, protein changes persisted after cells were returned to normal-viscosity medium, indicating a stable, plastic adaptation.
Implications for Treatment
The open microfluidic platform is designed to be compatible with standard multi-well plates, making it suitable for routine cell culture and high-throughput imaging.
"The findings suggest high viscosity may select for more invasive cells, and therapies targeting YAP signaling or cytoskeletal remodeling could be tested under realistic physical conditions."
This platform opens the door to:
- Screening drugs that target mechanosensitive pathways.
- Testing therapies under realistic physical tumor conditions.
- Adapting the device to study other cancers with viscosity gradients.